Workplace intervention for patients with neck/back pain worthwhile
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Invest to save: family planning in poorer countries
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Biosimilar gap discounts in USA may not reduce OOP costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Quality of care declines after removal of financial incentives
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Direct costs of polio rehabilitation high in Pakistan
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Optimise to economise on HIV costs in Africa
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Switching from warfarin reduces healthcare  use and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Benefits outweigh costs of increased CRC screening
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Publicly funded Weight Watchers cost effective in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

NICE call for evidence on CAR-T therapy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Low-dose versus high-dose colistin: cost saving, less toxicity
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Molecular testing for active TB saves hospital  costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Hidradenitis suppurativa increases indirect  costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

The Real Cost antismoking campaign saves  costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Cost-effective OCD treatment: CBT, SSRI or both?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Use of generic combination drugs would reduce expenditure
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Scale-up needed to meet WHO 2030 HCV target in Malaysia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Cryptococcal antigen screening cost effective in Uganda
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Ocrelizumab and alemtuzumab cost effective in RRMS
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Analysing high cost of allogeneic haematopoietic cell transplantation
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Hypertension control programme cost effective in Argentina
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Patients' WTP low for arbovirus vaccines in Guatemala
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Baricitinib and guanfacine listed in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Liver cancer costs post-sorafenib treatment in Germany
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

UC names chief of new medical school department
The University of Cincinnati has named James Herman as chair of the recently created Department of Pharmacology and Systems Physiology in the College of Medicine. The UC board of trustees approved the appointment of Herman, a researcher who will guide a department with 26 faculty, 50 staff and a budget of about $14 million. The department was created in July 2017 by merging the Department of Pharmacology and Cell Biophysics with the Department of Molecular and Cellular Physiology. The faculty have… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 31, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news

FDA Issues a Complete Response Letter for New Drug Application for Dasotraline for the Treatment of ADHD
MARLBOROUGH, Mass.--(BUSINESS WIRE) August 31, 2018 --Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for dasotraline, a... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 31, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Merck ’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients
KENILWORTH, N.J.--(BUSINESS WIRE) August 30, 2018 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Delstrigo, a once-daily fixed-dose combination... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Merck ’s Pifeltro (doravirine) for the Treatment of HIV-1 in Appropriate Patients
KENILWORTH, N.J.--(BUSINESS WIRE) August 30, 2018 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Pifeltro (doravirine, 100 mg), a new... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

Bayer Receives FDA Approval for Jivi (antihemophilic factor (recombinant), PEGylated-aucl) for Prophylactic Treatment of Hemophilia A
WHIPPANY, N.J., Aug. 30, 2018 /PRNewswire/ -- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Jivi ® (BAY94-9027, antihemophilic factor [recombinant] PEGylated-aucl) for the routine prophylactic treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

Meropenem for Injection, USP (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

Methyldopa Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

RPS warns of deadly DNP on BBC Wales News
Welsh Pharmacy Board member Sudhir Sehrawat has warned about the dangers of taking so-called‘diet drug’ DNP in order to lose weight. DNP is used in industry for a variety of purposes an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

Factors Impacting Diabetes Risk in HIV-infected Patients Factors Impacting Diabetes Risk in HIV-infected Patients
Is there an association between chronic hepatitis C and incidence of diabetes mellitus? What role might factors such as cirrhosis, duration of infection, and chronic hepatitis B infection play?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

New pain drugs may lower overdose and addiction risk
(Source: ScienceNOW)
Source: ScienceNOW - August 30, 2018 Category: Science Authors: Service, R. F. Tags: Biochemistry, Medicine, Diseases, Pharmacology, Toxicology In Depth Source Type: news

FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 29, 2018 Category: Drugs & Pharmacology Source Type: news

Can a New Radiopharmaceutical Company Unlock the Power of PET?
Since its invention and development in the 1970s, positron emission tomography (PET) has made an undeniable impact on cancer, neurology, and cardiology diagnosis. But the full potential of PET has been limited, primarily by cost and because the imaging technique relies on the use of radioactive isotopes to visualize physiological processes of the body and these isotopes tend to have short half-lives. Now, a new company based in Pasadena, CA, is trying to unlock the full power of PET with its radiolabeling platform that launched today. Fuzionaire Dx's technology is based on a breakthrough...
Source: MDDI - August 28, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

New Developments in Ovarian Cancer Treatment Are Showing Promise
Cancer is never an easy foe, but some types are more stubborn than others. Ovarian cancer is one of the hardest to treat. But there are signs of progress. Several recent studies have used new combination treatment strategies, including a drug that may make chemotherapy more effective and a drug originally designed to treat breast cancer. More research is needed, but the new studies provide hope for improving outcomes for women with advanced ovarian cancer, when there was little before. On its face, ovarian cancer isn’t actually more difficult to treat than other cancers like breast, prostate or lung. It is, technical...
Source: TIME: Health - August 28, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Innovation Health Source Type: news

Olaparib (LYNPARZA ®) Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Scotland to move premises in 2019
The Royal Pharmaceutical Society (RPS) has bought a property at 44 Melville Street in central Edinburgh that will become its new permanent home in Scotland from late 2019. Paul Bennett, RPS Chief Exe (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Pentothal (Thiopental Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Torecan (Thiethylperazine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Mintezol (Thiabendazole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Actisite (Tetracycline Periodontal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Effects of Biologics on Biliary Inflammation in PSC and IBD Effects of Biologics on Biliary Inflammation in PSC and IBD
Are the biological therapies used for the treatment of inflammatory bowel disease effective for the treatment of primary sclerosing cholangitis in patients with concomitant IBD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 28, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain
Pain-sensing sensory neurons of the dorsal root ganglion (DRG) can become sensitized or hyperexcitable in response to surgically induced peripheral tissue injury. We investigated the potential role and molecular mechanisms of nociceptive ion channel dysregulation in acute pain conditions such as those resulting from skin and soft tissue incision. We used selective pharmacology, electrophysiology, and mouse genetics to link increased current densities arising from the CaV3.2 isoform of T-type calcium channels (T-channels) to nociceptive sensitization using a clinically relevant rodent model of skin and deep tissue incision....
Source: Signal Transduction Knowledge Environment - August 28, 2018 Category: Science Authors: Joksimovic, S. L., Joksimovic, S. M., Tesic, V., Garcia-Caballero, A., Feseha, S., Zamponi, G. W., Jevtovic-Todorovic, V., Todorovic, S. M. Tags: STKE Research Articles Source Type: news

Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

Addyi (Flibanserin Tablets, for Oral Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenstr öm’s Macroglobulinemia
HORSHAM, Pa., August 27, 2018 – The Janssen Pharmaceutical Companies of Johnson& Johnson today announced the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with rituximab for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 27, 2018 Category: Drugs & Pharmacology Source Type: news